Industry News

Moderna Therapeutics opened a $110 million pharmaceutical manufacturing plant in July of 2018 in Norwood, Mass. Supporting phase one and two clinical development programs, the 200,000-sf facility will provide cGMP production and testing facilities for mRNA drug candidates, as well as housing a Personalized Cancer Vaccine (PCV) unit. Featuring sophisticated digital technologies for the integration of manufacturing operations, the building also houses quality control labs, plasmid production suites, preclinical labs, offices, and logistics space.

Rose-Hulman Institute of Technology will break ground in October of 2018 on a $29 million academic building in Terre Haute, Ind. Featuring a glass-walled atrium to showcase internal activities, the three-story, 60,000-sf facility will provide design studios, collaborative workspaces, faculty research suites, breakout rooms, and six flexible classrooms.

Iowa State University is planning a $28 million expansion of the Gerdin Business Building in Ames. Designed to enhance programmatic visibility, the collaborative 40,000-sf addition will provide classrooms, faculty offices, computer labs, study spaces, and a multipurpose atrium. The original structure was designed by ZGF Architects and completed in 2003. Construction will begin on the project in spring of 2019 with completion expected by 2021. 

Memorial University is building the $325 million Core Science Facility in St. John's, Newfoundland. Designed by HOK Architects and Hearn Fougere Architects to promote integration and interaction, the multidisciplinary project comprises three tower blocks offering teaching and research labs, offices, and technology-rich learning environments for the departments of biology, chemistry, biochemistry, and electrical and computer engineering.

Atara Biotherapeutics opened a $55 million manufacturing facility in June of 2018 in Thousand Oaks, Calif. Designed by HPA Architects to meet LEED sustainable design criteria, the Atara T-cell Operations and Manufacturing (ATOM) center houses a 90,000-sf facility for the production of CAR-T allogeneic therapies, as well as additional R&D labs and offices. The project was developed by Sares-Regis Group with Atara signing a 15-year lease for the building.